Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Cancers
|
October 23, 2021
Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article
Arthur Bobin, Cécile Gruchet, Stéphanie Guidez, et al.
Journal of Clinical Medicine
|
November 7, 2020
Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma Patients
Hélène Gardeney, Arthur Bobin, Cécile Gruchet, et al.
Leukemia & Lymphoma
|
October 21, 2021
Smoldering multiple myeloma: biology, clinical manifestations and management
Laly Nsiala, Arthur Bobin, Anthony Levy, et al.
Cancer Medicine
|
March 9, 2019
Long-term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98-LEDGF rearrangement
Maria Pilar Gallego Hernanz, José Miguel Torregrosa Diaz, Nathalie Sorel, et al.
Cancers
|
October 14, 2020
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
Arthur Bobin, Evelyne Liuu, Niels Moya, et al.
Blood Advances
|
August 27, 2025
Risk of synchronous and second primary malignancies in multiple myeloma transplant-ineligible treated with lenalidomide
Thomas Systchenko, Ialy Nsiala, Arthur Bobin, et al.
Expert Opinion on Drug Delivery
|
April 13, 2026
Review of the first on-body injector (obi) for the subcutaneous delivery of an oncology drug: isatuximab in multiple myeloma
Enrique M Ocio, Gurdeep Parmar, María-Victoria Mateos, et al.
British Journal of Haematology
|
May 7, 2026
A dexamethasone-free daratumumab-ixazomib regimen in frail elderly patients with relapsed or refractory multiple myeloma: Results of the IFM 2018-02 phase II study
Arthur Bobin, Margaret Macro, Cyrille Touzeau, et al.
Blood Cancer Journal
|
October 21, 2025
Debulking strategy prior to anti-BCMA/CD3 bispecific antibodies in extramedullary and/or high tumor burden RRMM: a retrospective cohort study
Thomas Chalopin, Elise Cellerin, Hélène Demarquette, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 15, 2025
Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort Study
Alexis Talbot, Cyrille Hulin, Aurore Perrot, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Cancers
|
October 23, 2021
Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article
Arthur Bobin, Cécile Gruchet, Stéphanie Guidez, et al.
Journal of Clinical Medicine
|
November 7, 2020
Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma Patients
Hélène Gardeney, Arthur Bobin, Cécile Gruchet, et al.
Leukemia & Lymphoma
|
October 21, 2021
Smoldering multiple myeloma: biology, clinical manifestations and management
Laly Nsiala, Arthur Bobin, Anthony Levy, et al.
Cancer Medicine
|
March 9, 2019
Long-term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98-LEDGF rearrangement
Maria Pilar Gallego Hernanz, José Miguel Torregrosa Diaz, Nathalie Sorel, et al.
Cancers
|
October 14, 2020
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
Arthur Bobin, Evelyne Liuu, Niels Moya, et al.
Blood Advances
|
August 27, 2025
Risk of synchronous and second primary malignancies in multiple myeloma transplant-ineligible treated with lenalidomide
Thomas Systchenko, Ialy Nsiala, Arthur Bobin, et al.
Expert Opinion on Drug Delivery
|
April 13, 2026
Review of the first on-body injector (obi) for the subcutaneous delivery of an oncology drug: isatuximab in multiple myeloma
Enrique M Ocio, Gurdeep Parmar, María-Victoria Mateos, et al.
British Journal of Haematology
|
May 7, 2026
A dexamethasone-free daratumumab-ixazomib regimen in frail elderly patients with relapsed or refractory multiple myeloma: Results of the IFM 2018-02 phase II study
Arthur Bobin, Margaret Macro, Cyrille Touzeau, et al.
Blood Cancer Journal
|
October 21, 2025
Debulking strategy prior to anti-BCMA/CD3 bispecific antibodies in extramedullary and/or high tumor burden RRMM: a retrospective cohort study
Thomas Chalopin, Elise Cellerin, Hélène Demarquette, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 15, 2025
Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort Study
Alexis Talbot, Cyrille Hulin, Aurore Perrot, et al.
Page
of 5